SHC Sotera Health Company: Market Capitalization to Book Value Ratio

Official company branding of Nordion (SHC)

Sotera Health Company (SHC) serves as a global guarantor of infection prevention, enjoying the absolute trust of pharmaceutical giants regarding sterilization. Business revenues rely on demand from medical centers, while financial stability remains high despite strict environmental regulations. The market price, currently at 7.94 as reflected in this chart, complements the description of a high-tech instrument decontamination network that creates a critical client dependency on its unique systems.

Nordion (SHC): Capitalization to Book Value Ratio from 07/04/2022 to 10/29/2026
Core merchandise of Sotera Health Corp

The capital-intensive model of Sotera Health Company (SHC), which requires massive expenditures for the construction of radiation complexes, makes the value of physical assets critical for valuation. Analyzing the ratio of the company's current market price to its net book value allows for the determination of the premium for brand and technology relative to equipment costs, helping investors assess the margin of safety and the risk of overpaying for the business.

Main competitors

A (Agilent Technologies) - Market Value to Book Value Ratio|questdiagnostics.com (DGX) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio ILMN (Illumina)|Market-to-Book Ratio Exact Sciences Corp|Market Capitalization to Book Value Ratio PerkinElmer RVTY|Capitalization to Book Value Ratio Bio-Rad Corp (BIO)|Market Capitalization to Book Value Ratio NNNN (Anbio Biotechnology)|quidel.com - Market Capitalization to Book Value Ratio|OPKO Health (OPK) - Market Value to Book Value Ratio|CDNA - Capitalization to Book Value Ratio|MRVI: Market Capitalization to Book Value Ratio|FLGT (Fulgent) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Standard BioTools Inc.|Market Value to Book Value Ratio cytekbio.com (CTKB)|OraSure - Market Cap to Net Assets Ratio|Market-to-Book Ratio XGN (exagen.com)|Market Value to Book Value Ratio MDXH|Market Capitalization to Book Value Lucid Diagnostics, Inc LUCD|Market Capitalization to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX: Market Capitalization to Book Value|trinitybiotech.com - Market Value to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|AIMD: Market Value to Book Value Ratio|Market Capitalization to Book Value CODX|Heart Test Laboratories - Market Value to Book Value Ratio|Market-to-Book Ratio biomerica.com BMRA|Market Cap to Net Assets Ratio Cardio Diagnostics Holdings (CDIO)|Market Cap to Book Value Multiple Virax Biolabs Group Limited VRAX|BJDX (Bluejay) - Market Capitalization to Book Value Ratio|AWH: Market-to-Book Ratio|Market Value to Book Value Ratio Accelerate Diagnostics AXDX|CENTOGENE (CNTG) - Market Value to Book Value|ENZ (Enzo Biochem Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Fresh2 (FRES)|Genetic Technologies (GENE) - Market Cap to Net Assets Ratio|Market Value to Book Value 23andMe Inc (ME)|Market Capitalization to Book Value Ratio Psychemedics